Bevacizumab (trade name Avastin, Genentech/Roche) is a humanized monoclonal antibody that recognizes and blocks vascular endothelial growth factor A (VEGF-A).
Bevacizumab (trade name Avastin, Genentech/Roche) is a drug that blocks the growth of new blood vessels. Bevacizumab is a humanized monoclonal antibody that recognizes and blocks vascular endothelial growth factor A (VEGF-A).